Real-world experience with tabelecleucel within and beyond the approval label

Kiavasch Mohammad Nejad Farid, Florian Kocher, Tobias Arnold, Josia Fauser, Elisa Henze, Christian Schultze-Florey, Carmen Diana Herling, Vladan Vučinić, Christian Reicherts, Matthias Stelljes, Raphael Stadelmann, Christof Scheid, Udo Holtick, Stavroula Masouridi-Levrat, Marc Wehrli, Urban Novak, Paul Schnitzler, Chiraz Ben-Salah, Isabelle Krämer, Anita Schmitt, Carsten Müller-Tidow, Thomas Luft, Peter Dreger, Michael Schmitt

Open source

DOI
10.1182/bloodadvances.2025019207
Published
2026-06-09
Container
Blood Advances
Publisher
American Society of Hematology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025019207,
  title = {Real-world experience with tabelecleucel within and beyond the approval label},
  author = {Kiavasch Mohammad Nejad Farid and Florian Kocher and Tobias Arnold and Josia Fauser and Elisa Henze and Christian Schultze-Florey and Carmen Diana Herling and Vladan Vučinić and Christian Reicherts and Matthias Stelljes and Raphael Stadelmann and Christof Scheid and Udo Holtick and Stavroula Masouridi-Levrat and Marc Wehrli and Urban Novak and Paul Schnitzler and Chiraz Ben-Salah and Isabelle Krämer and Anita Schmitt and Carsten Müller-Tidow and Thomas Luft and Peter Dreger and Michael Schmitt},
  year = {2026},
  journal = {Blood Advances},
  doi = {10.1182/bloodadvances.2025019207},
  url = {https://doi.org/10.1182/bloodadvances.2025019207}
}

RIS

TY  - JOUR
TI  - Real-world experience with tabelecleucel within and beyond the approval label
AU  - Kiavasch Mohammad Nejad Farid
AU  - Florian Kocher
AU  - Tobias Arnold
AU  - Josia Fauser
AU  - Elisa Henze
AU  - Christian Schultze-Florey
AU  - Carmen Diana Herling
AU  - Vladan Vučinić
AU  - Christian Reicherts
AU  - Matthias Stelljes
AU  - Raphael Stadelmann
AU  - Christof Scheid
AU  - Udo Holtick
AU  - Stavroula Masouridi-Levrat
AU  - Marc Wehrli
AU  - Urban Novak
AU  - Paul Schnitzler
AU  - Chiraz Ben-Salah
AU  - Isabelle Krämer
AU  - Anita Schmitt
AU  - Carsten Müller-Tidow
AU  - Thomas Luft
AU  - Peter Dreger
AU  - Michael Schmitt
PY  - 2026
JO  - Blood Advances
DO  - 10.1182/bloodadvances.2025019207
UR  - https://doi.org/10.1182/bloodadvances.2025019207
ER  - 

APA

Farid, K. M. N., Kocher, F., Arnold, T., Fauser, J., Henze, E., Schultze-Florey, C., Herling, C. D., Vučinić, V., Reicherts, C., Stelljes, M., Stadelmann, R., Scheid, C., Holtick, U., Masouridi-Levrat, S., Wehrli, M., Novak, U., Schnitzler, P., Ben-Salah, C., Krämer, I., Schmitt, A., Müller-Tidow, C., Luft, T., Dreger, P., & Schmitt, M. (2026). Real-world experience with tabelecleucel within and beyond the approval label. Blood Advances. https://doi.org/10.1182/bloodadvances.2025019207

Source records